EVLO stock forecast
Our latest prediction for Evelo Biosciences, Inc.'s stock price was made on the May 11, 2018 when the stock price was at 16.00$.
In the short term (2weeks), EVLO's stock price should outperform the market by 5.18%. During that period the price should oscillate between -2.23% and +4.15%.
In the medium term (3months), EVLO's stock price should outperform the market by 9.20%. During that period the price should oscillate between -5.04% and +11.51%.Get email alerts
About Evelo Biosciences, Inc.
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of monoclonal microbials, a modality of oral biologic medicines. It has three product candidates, EDP1066 and EDP1815 for the treatment of inflammatory diseases and EDP1503 for the treatment of cancer. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a profit of 2.59$ per share.
The book value per share is 5.20$
Three months stock forecastMay 11, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|